A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
8d agoen
From the article
Conditions : Glioma; Adult Interventions : Drug: HF1K16 Sponsors : HighField Biopharmaceuticals Corporation Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate
reuters.com·1mo ago
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
doi.org·6d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.